Medinet acquires additional 8% stake in Lymphotec - MarketLine Financial Deals

Medinet acquires additional 8% stake in Lymphotec

Medinet acquires additional 8% stake in Lymphotec - MarketLine Financial Deals
Medinet acquires additional 8% stake in Lymphotec
Published Sep 14, 2009
2 pages — Published Sep 14, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Medinet Co., Ltd. has acquired an additional 2,345 shares, representing 8% stake, in Lymphotec Inc., a medical research company.

  
Source:
Document ID
MA09406_090923
Country
Ticker
2370=JP
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Medinet acquires additional 8% stake in Lymphotec" Sep 14, 2009. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Medinet-acquires-additional-8-stake-in-Lymphotec-2052-9082>
  
APA:
MarketLine Financial Deals. (2009). Medinet acquires additional 8% stake in Lymphotec Sep 14, 2009. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Medinet-acquires-additional-8-stake-in-Lymphotec-2052-9082>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.